Cargando…
Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529581/ https://www.ncbi.nlm.nih.gov/pubmed/34690038 http://dx.doi.org/10.1016/j.ejca.2021.10.001 |
| _version_ | 1784586498586181632 |
|---|---|
| author | Fazio, Nicola Gervaso, Lorenzo Halfdanarson, Thorvardur R. La Salvia, Anna Hofland, Johannes Hernando, Jorge Sonbol, Mohamad B. Garcia-Carbonero, Rocio Capdevila, Jaume de Herder, Wouter W. Koumarianou, Anna Kaltsas, Gregory Rossi, Maura Grozinsky-Glasberg, Simona Oleinikov, Kira Boselli, Sabrina Tamayo, Darina Bagnardi, Vincenzo Laffi, Alice Rubino, Manila Spada, Francesca |
| author_facet | Fazio, Nicola Gervaso, Lorenzo Halfdanarson, Thorvardur R. La Salvia, Anna Hofland, Johannes Hernando, Jorge Sonbol, Mohamad B. Garcia-Carbonero, Rocio Capdevila, Jaume de Herder, Wouter W. Koumarianou, Anna Kaltsas, Gregory Rossi, Maura Grozinsky-Glasberg, Simona Oleinikov, Kira Boselli, Sabrina Tamayo, Darina Bagnardi, Vincenzo Laffi, Alice Rubino, Manila Spada, Francesca |
| author_sort | Fazio, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8529581 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85295812021-10-21 Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] Fazio, Nicola Gervaso, Lorenzo Halfdanarson, Thorvardur R. La Salvia, Anna Hofland, Johannes Hernando, Jorge Sonbol, Mohamad B. Garcia-Carbonero, Rocio Capdevila, Jaume de Herder, Wouter W. Koumarianou, Anna Kaltsas, Gregory Rossi, Maura Grozinsky-Glasberg, Simona Oleinikov, Kira Boselli, Sabrina Tamayo, Darina Bagnardi, Vincenzo Laffi, Alice Rubino, Manila Spada, Francesca Eur J Cancer Corrigendum Elsevier Ltd. 2022-01 2021-10-21 /pmc/articles/PMC8529581/ /pubmed/34690038 http://dx.doi.org/10.1016/j.ejca.2021.10.001 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Corrigendum Fazio, Nicola Gervaso, Lorenzo Halfdanarson, Thorvardur R. La Salvia, Anna Hofland, Johannes Hernando, Jorge Sonbol, Mohamad B. Garcia-Carbonero, Rocio Capdevila, Jaume de Herder, Wouter W. Koumarianou, Anna Kaltsas, Gregory Rossi, Maura Grozinsky-Glasberg, Simona Oleinikov, Kira Boselli, Sabrina Tamayo, Darina Bagnardi, Vincenzo Laffi, Alice Rubino, Manila Spada, Francesca Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title | Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title_full | Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title_fullStr | Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title_full_unstemmed | Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title_short | Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] |
| title_sort | corrigendum to ‘coronavirus disease 2019 in patients with neuroendocrine neoplasms: preliminary results of the intensive study’ [european journal of cancer 154 (2021) 246-252] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529581/ https://www.ncbi.nlm.nih.gov/pubmed/34690038 http://dx.doi.org/10.1016/j.ejca.2021.10.001 |
| work_keys_str_mv | AT fazionicola corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT gervasolorenzo corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT halfdanarsonthorvardurr corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT lasalviaanna corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT hoflandjohannes corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT hernandojorge corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT sonbolmohamadb corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT garciacarbonerorocio corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT capdevilajaume corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT deherderwouterw corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT koumarianouanna corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT kaltsasgregory corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT rossimaura corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT grozinskyglasbergsimona corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT oleinikovkira corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT bosellisabrina corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT tamayodarina corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT bagnardivincenzo corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT laffialice corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT rubinomanila corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 AT spadafrancesca corrigendumtocoronavirusdisease2019inpatientswithneuroendocrineneoplasmspreliminaryresultsoftheintensivestudyeuropeanjournalofcancer1542021246252 |